Alligator Bioscience Management
Management criteria checks 2/4
Alligator Bioscience's CEO is Søren Bregenholt, appointed in Jun 2021, has a tenure of 2.83 years. total yearly compensation is SEK5.20M, comprised of 68.9% salary and 31.1% bonuses, including company stock and options. directly owns 0% of the company’s shares, worth €23.94. The average tenure of the management team and the board of directors is 2.8 years and 2.8 years respectively.
Key information
Søren Bregenholt
Chief executive officer
kr5.2m
Total compensation
| CEO salary percentage | 68.9% |
| CEO tenure | 2.8yrs |
| CEO ownership | 0.00004% |
| Management average tenure | 2.8yrs |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | kr5m | kr4m | -kr249m |
| Sep 30 2023 | n/a | n/a | -kr232m |
| Jun 30 2023 | n/a | n/a | -kr231m |
| Mar 31 2023 | n/a | n/a | -kr213m |
| Dec 31 2022 | kr4m | kr3m | -kr193m |
| Sep 30 2022 | n/a | n/a | -kr177m |
| Jun 30 2022 | n/a | n/a | -kr163m |
| Mar 31 2022 | n/a | n/a | -kr152m |
| Dec 31 2021 | kr4m | kr2m | -kr142m |
Compensation vs Market: Søren's total compensation ($USD475.92K) is about average for companies of similar size in the German market ($USD401.52K).
Compensation vs Earnings: Søren's compensation has increased whilst the company is unprofitable.
CEO
Søren Bregenholt (52 yo)
2.8yrs
Tenure
kr5,201,000
Compensation
Mr. Søren Bregenholt, Ph D serves as the Chief Executive Officer at Alligator Bioscience AB (publ) since June 01, 2021. He served as the Chief Operating Officer of Symphogen A/S.Mr. Bregenholt served as S...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 2.8yrs | kr5.20m | 0.000040% SEK 23.9 | |
| Chief Financial Officer | 3.6yrs | no data | 0.011% SEK 6.4k | |
| Chief Technology Officer | 2.3yrs | no data | 0.00035% SEK 209.5 | |
| Chief Scientific Officer | 3.3yrs | no data | 0.0053% SEK 3.2k | |
| Director of Communications & Investor Relations | 2.7yrs | no data | no data | |
| Chief Medical Officer | 2.2yrs | no data | no data |
2.8yrs
Average Tenure
52yo
Average Age
Experienced Management: 7AL's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 1.9yrs | kr300.00k | no data | |
| Independent Chairman of the Board | 6.9yrs | kr700.00k | 0.015% SEK 9.2k | |
| Employee Representative Director | less than a year | no data | no data | |
| Independent Director | 2.8yrs | kr350.00k | no data | |
| Independent Vice Chairman of the Board | 2.8yrs | kr525.00k | 0.092% SEK 55.3k | |
| Independent Director | 1.9yrs | kr350.00k | no data | |
| Independent Director | 2.8yrs | kr350.00k | 0.0041% SEK 2.5k | |
| Independent Director | 4.9yrs | kr325.00k | no data |
2.8yrs
Average Tenure
61.5yo
Average Age
Experienced Board: 7AL's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.